Biotech | February 23, 2022
Taro to Acquire Alchemee from Galderma
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
he financing was significantly oversubscribed with high demand from both existing and new investors.
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
US $ 555,000 invested by Wavemaker Partners in pre-seed round
In the interim, Deepak Khanna will lead Human Health International.
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
Subscribe To Our Newsletter & Stay Updated
